Latest Episodes
RCC: Treating advanced RCC - The role of VEGFR-TKIs alone or in combination therapy
Prof. Thomas Powles, a Medical Oncologist from Barts Cancer Centre in the UK and Prof. Georg Hutterer, a Urologist from the Medical University of...
Colorectal and gastric cancer: Current and future therapeutic approaches. Part 3 - Future developments
In this podcast series, Dr. Jenny Seligmann (University of Leeds, UK), Dr. Autumn McRee (University of North Carolina, USA) and Dr. Dominik Modest (Charité...
Colorectal and gastric cancer: Current and future therapeutic approaches. Part 2 - Immunotherapy
In this podcast series, Dr. Jenny Seligmann (University of Leeds, UK), Dr. Autumn McRee (University of North Carolina, USA) and Dr. Dominik Modest (Charité...
Colorectal and gastric cancer: Current and future therapeutic approaches. Part 1 - Targeted therapy
In this podcast series, Dr. Jenny Seligmann (University of Leeds, UK), Dr. Autumn McRee (University of North Carolina, USA) and Dr. Dominik Modest (Charité...
Multiple Myeloma: Choosing the best treatment regimen in patients with relapsed/refractory MM - Part 2
In this medical education podcast series, myeloma experts Dr. Karthik Ramasamy (Haematologist and Associate Professor of Haematology at the Oxford University Hospitals in London,...
HCC: VEGFR-TKI monotherapy for unresectable or advanced HCC in 1st line setting
Prof. Josep Llovet and Prof. Stephen L. Chan discuss a very interesting topic about the use of the VEGFR TKIs monotherapy in the treatment...